← Back to Company DatabaseVisit Website
Viz.ai
AI-powered care coordination for time-sensitive diseases including cancer.
Series C+San Francisco, CAFounded 2016
About
Viz.ai uses AI to analyze medical imaging and coordinate care for critical conditions including cancer. Its platform automatically detects suspected diseases in imaging scans and alerts the appropriate specialists to accelerate treatment. While initially focused on stroke, the company has expanded its AI capabilities into oncology and other disease areas.
Total Funding
$250MKey Product
Viz.ai intelligent care coordination platformGeography
North AmericaKey Investors
Insight PartnersTiger GlobalGreenoaks
Focus Areas
AI / Machine LearningDiagnosticsPatient Navigation / Support
Technology
AI / Machine LearningImaging / RadiologyDigital Health / Software
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026